13F HOLDINGS REPORT
Pivotal bioVenture Partners Investment Advisor LLC
Quarter ended Q2 2025 · Filed August 13, 2025 · Accession 0001012975-25-000438
Total Value
$161.3M
Positions
12
Other Managers
1
Confidential Omitted
No
Holdings (12)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | OCULIS HOLDING AG | OCSAW | 2,300,774 | $44.7M | 27.68% |
| 2 | VAXCYTE INC | PCVX | 1,305,125 | $42.4M | 26.30% |
| 3 | ARCUTIS BIOTHERAPEUTICS INC | ARQT | 2,120,508 | $29.7M | 18.43% |
| 4 | INOZYME PHARMA INC | 45790W108 | 4,494,851 | $18.0M | 11.14% |
| 5 | ZENAS BIOPHARMA INC | ZBIO | 779,045 | $7.5M | 4.68% |
| 6 | TREVI THERAPEUTICS INC | TRVI | 1,146,110 | $6.3M | 3.89% |
| 7 | VIGIL NEUROSCIENCE INC | 92673K108 | 560,595 | $4.5M | 2.76% |
| 8 | RECURSION PHARMACEUTICALS IN | RXRX | 595,518 | $3.0M | 1.87% |
| 9 | BIOAGE LABS INC | BIOA | 653,374 | $2.7M | 1.67% |
| 10 | IO BIOTECH INC | IOBT | 864,197 | $1.2M | 0.74% |
| 11 | RALLYBIO CORP | RLYB | 2,404,644 | $812,770 | 0.50% |
| 12 | BOLT BIOTHERAPEUTICS INC | BOLT | 94,573 | $545,686 | 0.34% |